Strain Information | |
---|---|
Image | ![]() |
BRC No. | RBRC01922 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6;129-Zeb1<tm1Yhi> |
Former Common name | δ EF1 [Delta]C-fin, δ EF1 [Delta]C727 |
H-2 Haplotype | |
ES Cell line | E14 [129P2/OlaHsd] |
Background strain | |
Appearance | |
Strain development | Developed by Yujiro Higashi, Institute for Molecular and Cellular Biology, Osaka University. E14 ES cells were used. The mutant mice were backcrossed to C57BL/6 over 11 times. |
Strain description | Zeb1 gene knockout mice (deltaEF1 deltaC727). Exon 6 of the Zeb1 was replaced with a neo cassette. In the genetic background of inbred mouse strains, homozygous mutant mice die after birth. While about 20-30% of homozygous mice survive to adulthood in the mixed genetic background. |
Colony maintenance | |
References | Impairment of T cell development in deltaEF1 mutant mice. Higashi Y, Moribe H, Takagi T, Sekido R, Kawakami K, Kikutani H, Kondoh H J. Exp. Med., 185, 1467-1480 (1997). 9126927 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Zeb1 MGI:1344313 | zinc finger E-box binding homeobox 1 | 18 | Zeb1<tm1Yhi> MGI:1857515 | targeted mutation 1, Yujiro Higashi | |||
neo | neomycin resistance gene (E. coli) | 18 | SV40 early promoter and herpes simplex virus thymidine kinase promoter (HSV tk promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 19 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Thymidine kinase gene promoter sequence (HSV), neomycin resistance gene coding sequence (E. coli), SV40 early gene promoter and termination sequence (SV40), mouse Zeb1 genomic DNA |
Research application | Developmental Biology Research |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Exp. Med., 185, 1467-1480 (1997). The RECIPIENT should consult with the DEPOSITOR in the case of application for any patents or commercial use with the results derived from the use of the BIOLOGICAL RESOURCE. |
Depositor | Yujiro Higashi (Osaka University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |